A newly developed peptide called Tat-P4-(C5)2 is targets and only affects nerve changes that pose a problem resulting in chronic pain. Previous studies have also shown the peptide can also reduce addiction.
Pain
Pain Neuroscience news articles cover science research about pain receptors, nociceptors, nociception, sensory neurons, somatosensory cortex, chronic pain, acute pain, nocioceptors, musculoskeletal pain, therapies, phantom limb pain and other pain research.
Pain could be an under-recognized clinical manifestation for patients with specific autoantibodies that target neural proteins.
A new mathematical model can accurately reproduce experimental results on pain sensitivity and predict how the results are affected by the time of day.
A study of four drugs to combat chronic neuropathic pain finds Nortriptyline has the highest efficacious percentage and lowest quit rate.
WaTx, a short protein in the venom of Australian Black Rock scorpions, is helping researchers uncover new information about chronic pain and inflammation.
c-Fos accumulates in the nucleus of peripheral nerve cells of mouse models of chronic pain. Researchers identified around 30 existing drugs that appear to target the importin alpha-3-c-Fos pathway to help treat chronic pain.
A new study reports that pregnant women who take pregabalin, a drug commonly used to treat pain and anxiety, were three times more likely to have a child with a major birth defect.
Virtual reality helps to relieve pain and anxiety for children undergoing medical procedures, researchers report.
Higher pain intensity was linked to reductions in working memory ability and increased activity in the ventromedial prefrontal cortex.
A new study draws a link between some chronic pain syndromes and 'dry eye'.
The loss of TRESK significantly increases the risk of developing headaches and may be implicated in migraines.
